Revelation Biosciences, Inc. (REVB) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Revelation Biosciences, Inc. (REVB).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $2.55

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $3,913,230

Daily Volume: 0

Performance Metrics

1 Week: 2.41%

1 Month: -10.53%

3 Months: -70.64%

6 Months: -80.59%

1 Year: -95.21%

YTD: -88.48%

Company Details

Employees: 9

Sector: Health technology

Industry: Biotechnology

Country:

Details

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.

Selected stocks

Hess Midstream LP (HESM)

BP p.l.c. (BP)

Delek US Holdings, Inc. (DK)